Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Paclitaxel in Locally Recurrent or Metastatic Cervical Cancer
NCT00057863Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2003
- Primary completion
- Dec 2009
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, Paclitaxel Micelles for Injection in Cervical Cancer (CC), sponsored by National Cancer Institute. Started Jan 2003; status: completed.
02
Drugs
oxaliplatinPaclitaxel Micelles for Injection
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00057863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057863.